The International Diabetes Foundation (IDF) reports that as of 2013, 382 Mn individuals i.e. 8.3% of the global adult population is living with diabetes, and is expected that over the next 25 years, this population would rise beyond 592 Mn. The IDF also reports that with 175 Mn diabetes cases being currently undiagnosed, a large set of diabetic population is unknowingly heading towards disease related complications, thus adding to the potential yet avoidable disease burden. Additionally, 80% of the total diabetic patient pool lives in middle- and low-income countries, where the prevalence is on a phenomenal growth.
This report on global diabetes devices studies market for devices and equipment used for monitoring and treatment of diabetes. For the purpose of this report, the diabetes devices market is segmented into insulin delivery devices and glucose monitoring devices categories. The insulin delivery devices market is classified as insulin pumps, insulin syringes, insulin pens and insulin inhalers segments. Glucose test strips, lancing devices and lancets, glucose meters and continuous glucose monitors are the glucose monitoring devices studied in this report. This report presents the market size and forecast for each device segment for the period 2014-2023, along with respective CAGRs for the forecast during 2016-2023.
Geographically, the global diabetes market is studied for the following regional markets:
North America
a. U.S.
b. Canada
Europe
a. U.K.
b. Germany
c. Rest of Europe
Asia-Pacific
a. Japan
b. China
c. Rest of Asia-Pacific
Middle East and Africa
Latin America
The market size and forecast for the period 2014-2023 along with the CAGRs for the period 2016-2023 for the mentioned segments are also presented in this study. Cumulative presentation, market size and forecast of insulin delivery devices and glucose monitoring devices for individual country level markets are also provided in this report.
Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included in this study for studying the global market competition. The report concludes with company profiles section that highlights key information about the major market players operating in the global diabetes devices market.
Insulin pumps, syringes, pens and inhalers are the major insulin delivery devices segments studied in this market.
Escalating geriatric population, increasing sedentary lifestyle, obesity, heightening prevalence of diabetes, technological advancements and growing awareness in patient population are the key drivers of insulin delivery devices market. North America is the largest market for insulin delivery devices. High prevalence of diabetes in the U.S., growing geriatric population and evolved reimbursement system are the key drivers of this market. The Europe insulin delivery devices market is on a steady growth due to aging population, disease prevalence and high trend of adoption of novel therapeutics in the region. Asia-Pacific and Middle East and Africa will witness significant growth during the forecast period. Phenomenal rise in disease prevalence, growing awareness about new diabetes treatments, rapid development of healthcare infrastructure in these regions are the prime market drivers.
This report on diabetes devices categorizes the glucose monitoring devices segment into:
Glucose monitoring is the most vital part of the overall diabetes management process. Awareness initiatives such as government and non-profit campaigns and conferences about diabetes management, prevention of disease related complications and benefits of regular monitoring have resulted in growing demand for novel glucose monitoring devices. Continuous glucose monitoring allows perpetual and swift detection and reporting of blood glucose levels by utilizing smart sensors. By continuously reporting blood glucose levels at regular intervals, continuous glucose monitors facilitates the patients in taking required decisions about dosage measurements. Benefits such as early and regular blood glucose readings, connectivity with smartphones, hence, easy diabetes management are the prime factors that support the growing demand for continuous glucose monitors market.
Based on geographical segmentation, the global diabetes devices market is studied for:
The global diabetes devices market is currently led by North America and Europe. United States is the largest contributor to the overall market revenue. High disease prevalence, awareness in the patient population and better reimbursement policies majorly contribute to the dominance of these regional markets. Asia-Pacific, Middle East and Africa, and Latin America markets will witness higher growth against that of the global growth. Phenomenal rise in diabetes prevalence in Asia, and other middle- and low-income countries, increasing healthcare expenditure, growing awareness about effective diabetes management are the major drivers of these markets. Some of the prime national markets in these regions are India, China, Russia, Saudi Arabia and others.
